Education
About Us
Working with TipRanks
Follow Us
Viridian Therapeutics (VRDN)
NASDAQ:VRDN
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 70.85M | $ 302.00K | $ 314.00K | $ 1.77M | $ 2.96M |
| Gross Profit | $ 69.69M | $ 302.00K | $ 314.00K | $ 1.77M | $ 2.96M |
| Operating Income | $ -363.39M | $ -299.04M | $ -254.45M | $ -134.30M | $ -79.73M |
| EBITDA | $ -337.65M | $ -265.66M | $ -235.37M | $ -129.13M | $ -79.29M |
| Net Income | $ -342.60M | $ -269.95M | $ -237.73M | $ -129.87M | $ -79.41M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 874.65M | $ 717.58M | $ 477.37M | $ 424.55M | $ 196.97M |
| Total Assets | $ 899.42M | $ 742.40M | $ 490.42M | $ 435.09M | $ 203.71M |
| Total Debt | $ 50.69M | $ 21.09M | $ 21.05M | $ 5.26M | $ 520.00K |
| Net Debt | $ -161.69M | $ -78.50M | $ -81.78M | $ -150.32M | $ -41.78M |
| Total Liabilities | $ 177.25M | $ 70.76M | $ 48.40M | $ 40.03M | $ 15.99M |
| Stockholders' Equity | $ 722.17M | $ 671.64M | $ 442.02M | $ 395.06M | $ 187.72M |
| Cash Flow | |||||
| Free Cash Flow | $ -276.89M | $ -232.83M | $ -185.07M | $ -94.64M | $ -54.92M |
| Operating Cash Flow | $ -276.39M | $ -232.32M | $ -184.17M | $ -93.84M | $ -54.58M |
| Investing Cash Flow | $ -37.56M | $ -228.65M | $ -94.25M | $ -115.13M | $ -74.29M |
| Financing Cash Flow | $ 426.74M | $ 457.74M | $ 225.67M | $ 322.24M | $ 125.28M |